Peripheral lymphocyte markers as surrogate measures of immunosuppression and post-transplant clinical states

Clinical and Applied Immunology Reviews

Volumn 4, Issue 4, 2004, Pages 225-238

  Sindhi, Rakesh ^a   Magill, Amy ^a   Manavalan, Sanil ^b   Yost, Mary ^a   Halusczyak, Catherine ^a   Zeevi, Adriana ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b Department of Pathology ^*  (United States)

Author keywords

Graft adaptation; Immunosuppression; Lymphocyte subsets; Rejection; Stimulated lymphocyte responses (sLR)

Indexed keywords

CD28 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE SURFACE MARKER; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ACCURACY; ALLOIMMUNITY; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; CELLULAR DISTRIBUTION; CLINICAL OBSERVATION; CLINICAL TRIAL; CONCENTRATION RESPONSE; DRUG BLOOD LEVEL; DRUG POTENTIATION; EFFECTOR CELL; GRAFT REJECTION; GRAFT SURVIVAL; HELPER CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGICAL MONITORING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; NEPHROTOXICITY; NEUROTOXICITY; ORGAN TRANSPLANTATION; PERIPHERAL LYMPHOCYTE; PHARMACODYNAMICS; PHENOTYPE; PRIORITY JOURNAL; RECIPIENT; REVIEW; T LYMPHOCYTE; TREATMENT FAILURE; VALIDATION PROCESS;

EID: 1842864964     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cair.2004.01.002     Document Type: Review

References (18)

1. 2000 Annual Report of the U.S. Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data 1989-1998. (2001; February 16) Rockville, MD and Richmond, VA: HHS/HRSA/OSP/DOT and UNOS.
2. Borel J.F. Feurer C. Gubler H.U. Stahelin H. Biological effects of cyclosporine A: a new antilymphocytic agent Agents & Actions 6 4 1976 468-475
3. Liu J. Farmer J.D.J. Lane W.S. Friedman J. Weissman I. Schreiber S. Calcineurin is a common target of immunophilin-cyclosporine A and FKBP-FK506 complexes Cell 66 1991 807-815
4. Kasiske B.L. Heim-Duthoy K. Rao K.V. Awni W.M. The relationship between cyclosporine pharmacokinetic parameters and subsequent acute rejection in patients undergoing renal transplantation Transplantation 46 1988 716-722
5. Kahan B.D. Keown P. Levy G.A. Johnston A. Therapeutic drug monitoring of immunosuppressant drugs in clinical practice Clin Ther 24 3 2002 330-350
6. Sollinger H.W. Mofetil study sroup Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients Transplantation 60 1995 225-232
7. MacDonald A.S. Global study group (Writing committee-Falk Michael, MacDonald A, Nanni Giuseppe N, and Sindhi R): A worldwide, phase III, randomized, controlled safety and efficacy study ofolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts Transplantation 71 2 2001 271-280
8. Kahan B.D. Efficacy of SRL compared with Azathioprine for reduction of acute renal allograft rejection: a randomized multicenter study. The Rapamune US Study Group Lancet 356 9225 2000 194-202
9. Jung T. Schauer U. Heusser C. Neumann C. Reigler C.H.L. Detection of intracellular cytokines by flow cytometry J Immunol Methods 159 1993 197-207
10. Van den Berg A. Twilhaar W. Mesander G. van Son W.J. van der Bij W. Klompmaker I.J. et al. Quantitation of immunosuppression by flow cytometric measurement of the capacity of T cells for interleukin-2 production Transplantation 65 8 1998 1066-1071
11. Soldin S.J. Immunophilins: their properties and their potential role in therapeutic drug monitoring Ther Drug Monit 22 1 2000 44-46
12. Sindhi R. LaVia M.F. Paulling E. Shaw S. Sindhi L.A. Livingston R. et al. Intracellular IL-2 response of stimulated peripheral lymphocytes may distinguish cyclosporine effect in renal transplant recipients Transplantation 69 3 2000 432-436
13. Sindhi R. Allaert J. Gladding D. Koppelman B. Dunne J.F. Cytokines and cell-surface receptors as target endpoints of immunosuppression with cyclosporine A J Interferon Cytokine Res 21 7 2001 507-514
14. Sindhi R. Allert J. Gladding D. Haaland P. Dunne J. Sehgal S. Modeling individual variation in biomarker response to combination immunosuppression-potential clinical implications J Immunol Methods 272 1-2 2003 257-272
15. Muller T.F. Grebe S.O. Neumann M.C. Heymanns J. Radsak K. Sprenger H. Lange H. Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies Transplantation 64 10 1997 1432-1437
16. Kemper C. Chan A.C. Green J.M. Brett K.A. Murphy K.M. Atkinson J.P. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype Nature 421 6921 2003 388-392
17. Ciubotariu R. Vasilescu R. Ho E. Cinti P. Cancedda C. Poli L. et al. Detection of T suppressor cells in Patients with organ allografts Hum Immunol 62 2001 15-20
18. Lesko L.J. Atkinson Jr. A.J. Use of biomarkers and surrogate endpoints in drug development and regulatory decision-making: criteria, validation, strategies Annu Rev Pharmacol Toxicol 41 2001 347-366